Home › Core › ISCC-IDs › 28C5DRMXw14Jo

View ISCC-ID

Core Data

28C5DRMXw14Jo
ISCC-ID - digital asset identifier
CCKrRzw4U1BTy-CTA9hCHw46eJ3-CDiDyhrhVHHns-CRZ7JHkKg2AUC
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

figure 4 keap1ko reduces trametinibinduced ros through increased glutathione synthesis

Ledger Reference

coblo
Source Ledger/Blockchain
4832
N-th ISCC Decleration on source ledger
2f0aac600ceaa3a7618a4356ceb8a479fd171877fda82eba73647ffc423a76a8
Hash of block that includes the ISCC-DECLARATION
e2aadf6e8dd2be5f4fac81a49f6c7524a1f6c008400740077c4ca7322573ce02
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Figure 4. KEAP1-KO reduces trametinib-induced ROS through increased glutathione synthesis.", "@type": "ScholarlyArticle", "genre": "component", "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://cdn.elifesciences.org/articles/18970/elife-18970-v3.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "eLife Sciences Organisation, Ltd.", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.7554/elife.18970.015", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCKrRzw4U1BTy-CTA9hCHw46eJ3-CDiDyhrhVHHns-CRZ7JHkKg2AUC", "propertyID": "ISCC"}], "datePublished": null}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close